Sonia Izquierdo

A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus–Advanced Fibrosis

Sonia Alonso López, María Luisa Manzano, Francisco Gea et al. · Hepatology · 2020 · 96 citations

Medicine, Oncology, Hepatology +16

Therapy with ombitasvir/paritaprevir/ritonavir plus dasabuvir is effective and safe for the treatment of genotypes 1 and 4 hepatitis C virus (<scp>HCV</scp>) infection in patients with severe renal impairment: A multicentre experience

Raquel Muñoz-Gómez, Diego Rincón, Adriana Ahumada et al. · Journal of Viral Hepatitis · 2016 · 42 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Impact of age- and gender-specific cut-off values for the fecal immunochemical test for hemoglobin in colorectal cancer screening

Cristina Álvarez–Urturi, Montserrat Andreu, Francisco Pérez‐Riquelme et al. · Digestive and Liver Disease · 2016 · 29 citations

Medicine, Hematology, Oncology +16

Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cure

Georg Semmler, Sonia Alonso López, Mònica Pons et al. · Journal of Hepatology · 2024 · 26 citations · Full text

Medicine, Pharmacotherapy, Hepatic Pharmacotherapy +11

Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cure

Georg Semmler, Sonia Alonso López, Mònica Pons et al. · Hepatology · 2024 · 14 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +17